Etretinate

阿维A酯

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameEtretinate
Drug Alias Nameetretinatum芳香维甲酸依曲替酯etretinato替维甲苯壬四烯酯 +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinoic acid receptors agonists
TargetsRetinoic acid receptors
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsPsoriasis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1986/09/30
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesF. Hoffmann-La Roche Ltd
Inactive CompaniesN/A
Active IndicationsPsoriasis
Inactive IndicationsN/A

Other Information

ATC CodeD05BB01
Related LinksWikipediaDrugBankKEGG